VROOM

Project summary:

A multi-centre randomised controlled trial examining the effects of temporarily suspending low-dose methotrexate treatment for two weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory condition.

Funders

National Institute for Health Research (NIHR) Efficacy and Mechanism Evaluation (EME) programme

Leader researcher:

Professor Abhishek Abhishek

Lead institution:

The University of Nottingham

Vaccine type:

Pfizer

Recruitment for clinical trial open:

Yes

Website:

Visit the VROOM website